![]() Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. | ||
Founding Date | Founding Date 2001 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Lund, SE HQ | Locations Waltham, US HQ |
Employees | Employees 1555% decrease | Employees 69 |
Valuation ($) | Valuation ($) 59 m | Valuation ($) 43.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) kr514k (FY, 2025) | Revenue (est.) $43.8m (FY, 2025) |
Net income | Net income (kr51.4m) (FY, 2025) | Net income ($35m) (FY, 2025) |

Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.
View company